Viveve Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Viveve Medical generated cash of -$12,878,000, which is more than the previous year. Cash used in financing activities reached the amount of $25,973,000 last year. Net change in cash is therefore $12,639,000.
Cash Flow
| 2012 | -3.16M | -74K | 920K |
|---|---|---|---|
| 2013 | -4.80M | 0 | 5.32M |
| 2014 | -5.99M | -117K | 6.57M |
| 2015 | -12.19M | -109K | 18.76M |
| 2016 | -18.08M | -256K | 19.06M |
| 2017 | -34.85M | -3.40M | 50.90M |
| 2018 | -43.09M | -2.14M | 54.02M |
| 2019 | -31.23M | -1.08M | 16.10M |
| 2020 | -15.23M | -781K | 9.23M |
| 2021 | -12.87M | -456K | 25.97M |
VIVE Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.52M | 13.30M | 29.52M | 20.73M | 8.08M | 7.36M | 895K | 430K | 258K | 2.58M |
Operating activities | ||||||||||
Net income | -22.02M | -21.91M | -42.52M | -49.98M | -36.95M | -20.11M | -12.42M | -6.18M | 3.49M | -8.38M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.13M | 1.29M | 1.18M | 786K | 449K | 111K | 77K | 56K | 53K | 43K |
Stock-based compensation expense | 3.77M | 2.65M | 2.4M | 0 | 1.87M | 981K | 220K | 184K | 201K | 544K |
| Deferred income tax benefit | 3.77M | 2.65M | 2.4M | 0 | 1.87M | 981K | 220K | 184K | 201K | 544K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 96K | 349K | 3.10M | 330K | -3.90M | -1.49M | -587K | -6K | -80K | 48K |
Inventories | 2.20M | 1.36M | -1.07M | -1.98M | -67K | -1.23M | -1.43M | 97K | 42K | 56K |
Accounts payable | 599K | -727K | -2.38M | -805K | 1.71M | 1.65M | 1.01M | -551K | 48K | 228K |
Cash generated by operating activities | -12.87M | -15.23M | -31.23M | -43.09M | -34.85M | -18.08M | -12.19M | -5.99M | -4.80M | -3.16M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -456K | -781K | -1.08M | -2.14M | -905K | -256K | -109K | -117K | 0 | -74K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -456K | -781K | -1.08M | -2.14M | -3.40M | -256K | -109K | -117K | 0 | -74K |
Financing activities | ||||||||||
Common Stock Issued | 25.82M | 341K | 16.27M | 53.79M | 31.56M | 13.88M | 16.43M | 4.20M | 0 | 0 |
Payments for dividends | 0 | 0 | -378K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 704K | 341K | 0 | 233K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -3.98M | -1.34M | 0 | 0 | 19.21M | -4.83M | 2.33M | -1.63M | 0 | 0 |
Cash used in financing activities | 25.97M | 9.23M | 16.10M | 54.02M | 50.90M | 19.06M | 18.76M | 6.57M | 5.32M | 920K |
Net Change In Cash | 12.63M | -6.78M | -16.21M | 8.79M | 12.64M | 726K | 6.46M | 465K | 511K | -2.32M |
Cash at end of period | 19.16M | 6.52M | 13.30M | 29.52M | 20.73M | 8.08M | 7.36M | 895K | 769K | 258K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |